Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Martinez, Jessica A.
Thomson, Cynthia A.
Thompson, Patricia A.
Villa-Guillen, Diana Evelyn
Chow, H-H. Sherry
Funding for this research was provided by:
National Cancer Institute (1R01CA172444-01A1)
Susan G. Komen for the Cure (CCR14299136)
unspecified valid from 2016-07-19